Adagene Inc (ADAG)
2.27
-0.10
(-4.22%)
USD |
NASDAQ |
Nov 14, 16:00
2.27
0.00 (0.00%)
After-Hours: 20:00
Adagene EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | -0.3086 |
| September 30, 2020 | -0.329 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.1413 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.329
Minimum
Sep 2020
-0.1413
Maximum
Dec 2019
-0.2596
Average
-0.3086
Median
Dec 2020
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -0.52 |
| Zai Lab Ltd | -0.80 |
| China SXT Pharmaceuticals Inc | -- |
| LakeShore Biopharma Co Ltd | -0.1565 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | 29.78M |
| Earnings Yield | -31.94% |
| Normalized Earnings Yield | -20.33 |